KEMPHARM INC's ticker is and the CUSIP is 488445AB3. A total of 4 filers reported holding KEMPHARM INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,230,000 | -2.6% | 3,000,000 | 0.0% | 0.18% | +24.2% |
Q3 2019 | $1,263,000 | -9.5% | 3,000,000 | 0.0% | 0.15% | +8.8% |
Q2 2019 | $1,395,000 | -6.8% | 3,000,000 | 0.0% | 0.14% | -31.5% |
Q1 2019 | $1,496,000 | -0.9% | 3,000,000 | 0.0% | 0.20% | -12.3% |
Q4 2018 | $1,509,000 | -15.7% | 3,000,000 | 0.0% | 0.23% | +82.4% |
Q3 2018 | $1,789,000 | -10.8% | 3,000,000 | 0.0% | 0.12% | -10.7% |
Q2 2018 | $2,005,000 | -2.9% | 3,000,000 | 0.0% | 0.14% | -14.1% |
Q1 2018 | $2,065,000 | +11.6% | 3,000,000 | 0.0% | 0.16% | +37.0% |
Q4 2017 | $1,851,000 | +1.4% | 3,000,000 | 0.0% | 0.12% | 0.0% |
Q3 2017 | $1,826,000 | -1.9% | 3,000,000 | 0.0% | 0.12% | -6.3% |
Q2 2017 | $1,862,000 | – | 3,000,000 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 75,000,000 | $57,250,000 | 1.98% |
DSC Advisors, L.P. | 8,250,000 | $6,112,000 | 1.28% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,000,000 | $2,065,000 | 0.16% |